For modern sponsors and CROs, decentralized clinical trials (DCTs) have increasingly become a strategic priority, especially after the COVID-19 pandemic.  Once perceived merely as nice-to-have pilot projects, DCTs, which are basically trials that are conducted remotely, outside traditional study sites, and through local healthcare providers with a view to improving the patient experience, first came […]

In conversation with Mr. Hiren Thakkar, MD, Octalsoft As we settle into 2023 with a refreshed mindset, we take inventory of what is important and focus on our goal to continuously make sure that we are maximizing the impact of data on the global disease burden with more inclusive, patient-friendly trials. Speaking to Mr. Hiren […]

Artificial Intelligence (AI) and Machine Learning (ML) have emerged as powerful tools with the potential to transform various industries, and healthcare is no exception. In recent years, these technologies have gained significant traction in the field of clinical trials, revolutionizing the way new therapies and treatments are developed, evaluated, and brought to market.  By harnessing […]